Patents by Inventor Michal SCHWARTZ-EISENBACH

Michal SCHWARTZ-EISENBACH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING NEURODEGENERATIVE DISEASES BY INDUCING DISEASE-ASSOCIATED MICROGLIA (DAM) CELLS
    Publication number: 20190367623
    Abstract: An active agent that causes an increase in the number of disease-associated microglia (DAM) for use in treating a neurodegenerative disease is provided.
    Type: Application
    Filed: January 17, 2018
    Publication date: December 5, 2019
    Inventors: Michal SCHWARTZ-EISENBACH, Ido AMIT, Hadas KEREN-SHAUL, Amit SPINRAD, Assaf WEINER, Orit MATCOVITCH NATHAN, Raz DVIR
  • Modified kisspeptin peptides and uses thereof
    Patent number: 10072044
    Abstract: The present application provides synthetic modified peptides of five to seven natural or non-natural amino acids as well as pharmaceutical compositions comprising them, for use in the treatment a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, depression or cognitive impairment, particularly schizophrenia and Alzheimer's disease.
    Type: Grant
    Filed: June 12, 2016
    Date of Patent: September 11, 2018
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Michal Schwartz-Eisenbach, Matityahu Fridkin, Michal Cardon-Yaakov
  • TREATMENT OF CNS INFLAMMATORY DISORDERS
    Publication number: 20170348393
    Abstract: A method of upregulating an anti-inflammatory response in a central nervous system (CNS) of a subject in need thereof is disclosed. The method comprising locally administering to the CNS of the subject a therapeutically effective amount of IFN-beta, thereby upregulating the anti-inflammatory response in the CNS of the subject. Methods of treating an inflammation in a CNS or treating a disease, disorder, condition or injury of a CNS of a subject are also disclosed.
    Type: Application
    Filed: November 5, 2015
    Publication date: December 7, 2017
    Inventors: Michal SCHWARTZ-EISENBACH, Ido AMIT, Merav COHEN, Orit MATCOVICH
  • MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
    Publication number: 20160280739
    Abstract: The present application provides synthetic modified peptides of five to seven natural or non-natural amino acids as well as pharmaceutical compositions comprising them, for use in the treatment a disease or disorder presenting behavioral abnormalities associated with impairment of sensory gating function, depression or cognitive impairment, particularly schizophrenia and Alzheimer's disease.
    Type: Application
    Filed: June 12, 2016
    Publication date: September 29, 2016
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Michal SCHWARTZ-EISENBACH, Matityahu FRIDKIN, Michal CARDON-YAAKOV